Dietary Fats Shape Pancreatic Cancer Risk via Ferroptosis
Publication Title: Diet-induced phospholipid remodeling dictates ferroptosis sensitivity and tumorigenesis in the pancreas.
Summary
- Question
- This study investigated how dietary fat composition influences the development of pancreatic ductal adenocarcinoma (PDAC), a highly lethal form of cancer. The researchers focused on the role of unsaturated fatty acids, specifically monounsaturated fatty acids (MUFAs) like oleic acid (found in olive oil) and polyunsaturated fatty acids (PUFAs) like linoleic acid (found in vegetable oils), in tumor progression and sensitivity to ferroptosis, a type of cell death caused by lipid oxidation.
- Why it Matters
- PDAC has a very low survival rate and limited treatment options, making prevention strategies critical. This research provides insight into how dietary fat composition—not just total fat intake—may affect PDAC risk. Understanding how specific fats influence tumor development could inform dietary recommendations and 'precision nutrition' strategies to reduce cancer risk. The findings also highlight ferroptosis as a potential tumor-suppressive mechanism, which could guide new therapeutic approaches.
- Methods
- The researchers used a mouse model genetically engineered to mimic human PDAC progression. They fed the mice isocaloric high-fat diets (HFDs) with different fat sources, reflecting common human dietary patterns, for up to 12 weeks. They measured tumor burden, analyzed pancreatic tissue for lipid composition, and assessed sensitivity to ferroptosis. Human data from the UK Biobank were also analyzed to examine correlations between plasma fatty acid levels and PDAC risk.
- Key Findings
- Diets rich in oleic acid (a MUFA) significantly increased pancreatic tumor development, while diets high in linoleic acid (a PUFA) suppressed it. The composition of dietary fats altered the lipid makeup of pancreatic cell membranes, affecting lipid oxidation and ferroptosis sensitivity. High MUFA intake reduced susceptibility to ferroptosis, while high PUFA intake enhanced it. Human data supported these findings, showing higher circulating MUFA levels were associated with increased PDAC risk, while higher PUFA levels were protective.
- Implications
- The study suggests that dietary fat composition could be a modifiable risk factor for PDAC. Specifically, increasing PUFA intake may help prevent tumor development by promoting ferroptosis sensitivity in pancreatic cells. These findings could lead to tailored dietary recommendations for individuals at high risk of PDAC, such as those with genetic predispositions. Additionally, the study underscores the importance of ferroptosis in cancer prevention and its potential as a therapeutic target.
- Next Steps
- Future research should explore whether these findings can be replicated in human populations through interventional dietary studies. Additionally, studies should investigate the molecular mechanisms behind the sex-specific differences observed in tumor response to MUFA and PUFA intake. Finally, researchers could focus on identifying the triggers for ferroptosis in pancreatic cells to better understand how to harness this process for cancer prevention and treatment.
- Funding Information
- This research was supported by the National Institutes of Health (awards T32-CA193200, R01-DK090489, R01-DK126447, DP2-CA248136, P30-CA016359, and R01-CA276108-03S1). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Full Citation
Ruiz CF, Ge X, McDonnell R, Agabiti SS, McQuaid DC, Tang A, Kharwa M, Goodell J, Saavedra-Pena RDM, Wing A, Li G, Medici NP, Robert ME, Varshney RR, Rudolph MC, Gorelick FS, Wysolmerski J, Canals D, Haley JD, Rodeheffer MS, Muzumdar MD. Diet-induced phospholipid remodeling dictates ferroptosis sensitivity and tumorigenesis in the pancreas. Cancer Discov 2026 PMID: 42053430, DOI: 10.1158/2159-8290.CD-25-0734.
Authors
Christian Felipe Ruiz, PhD
First AuthorAssociate Research Scientist in Genetics
Mandar Deepak Muzumdar, MD
Last AuthorAssociate Professor of Genetics and of Internal Medicine (Medical Oncology).